Author

Emily Malloy

Fox Chase Cancer Center

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1 Assay:clinical cohort / trial· 1 Approach:experimental assay· 1 Organism:human· 1 Organism:mouse· 1 Assay:proteomics· 1

Frequent Co-Authors

Andres J. Klein–SzantoiD· 1 shared Ariana Musa de AquinoiD· 1 shared Charline OgieriD· 1 shared Debora Barbosa Vendramini CostaiD· 1 shared Dmitry I. ZhigareviD· 1 shared Edna CukiermaniD· 1 shared Esteban Martı́neziD· 1 shared Hayan LeeiD· 1 shared

Activity by Year

2024-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Andres J. Klein–SzantoORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Netrin G1 Ligand is a new stromal immunomodulator that promotes pancreatic cancer

Debora Barbosa Vendramini Costa, Ralph Francescone, Janusz Franco‐Barraza, Tiffany Luong, Myree Graves, Ariana Musa de Aquino, Nina G. Steele, Jaye C. Gardiner, Sérgio Alexandre Alcântara dos Santos, Charline Ogier, Emily Malloy, Leila Borghaei, Esteban Martı́nez, Dmitry I. Zhigarev, Yinfei Tan, , Edna Cukierman

This paper identifies NGL-1 as a stromal immunomodulator in pancreatic cancer that promotes tumor growth by modulating the tumor microenvironment through TGF-β and transcription factor pathways.

bioRxiv · May 15, 2024 · PreprintCancer Biology